1998
DOI: 10.1136/jcp.51.10.716
|View full text |Cite
|
Sign up to set email alerts
|

Proliferation markers in tumours: interpretation and clinical value.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
125
0
21

Year Published

2000
2000
2019
2019

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 187 publications
(148 citation statements)
references
References 135 publications
2
125
0
21
Order By: Relevance
“…2 However, the growth fraction, i.e., the proportion of cells committed to the cycle, may be easily assessed by Ki-67 or MIB-1 antibodies, which identify antigens expressed in the G 1 , S and G 2 phases of the cell cycle. 3,4 In particular, SPF, besides being the gold standard technique, 5 can be assessed by immunohistochemical detection of PCNA, a 36 kDa auxiliary protein of DNA polymerase-delta nuclear protein involved in DNA synthesis, with a relevant correlation to the proliferative state of the cell. 6 Besides the relevance of studies on several markers, it was mandatory to investigate the risk factors of continued use of tobacco, alcohol misuse, diet and viral infections.…”
mentioning
confidence: 99%
“…2 However, the growth fraction, i.e., the proportion of cells committed to the cycle, may be easily assessed by Ki-67 or MIB-1 antibodies, which identify antigens expressed in the G 1 , S and G 2 phases of the cell cycle. 3,4 In particular, SPF, besides being the gold standard technique, 5 can be assessed by immunohistochemical detection of PCNA, a 36 kDa auxiliary protein of DNA polymerase-delta nuclear protein involved in DNA synthesis, with a relevant correlation to the proliferative state of the cell. 6 Besides the relevance of studies on several markers, it was mandatory to investigate the risk factors of continued use of tobacco, alcohol misuse, diet and viral infections.…”
mentioning
confidence: 99%
“…Correlation between high proliferative activity and worse prognosis for laryngeal and head and neck tumors has shown, particularly for neoplasms invading structures located adjacently to the tumor's site of origin 4,5,8,9 . This study aims to relate the immunohistochemical expression of gene p53 and antibody Ki-67 to established prognostic factors (age, histological grade, lymph node status, and disease staging) in patients with laryngeal epidermoid carcinoma.…”
Section: Introductionmentioning
confidence: 99%
“…Cell proliferation is also seen as a fundamental biologic mechanism in oncogenesis 8 and in the detection of cell growth fraction markers such as antibody Ki-67, used as a prognostic factor in a wide variety of tumors [9][10][11] .…”
Section: Introductionmentioning
confidence: 99%
“…Essa proteína não está envolvida no sistema de reparação do DNA, e sua expressão restringe-se aos compartimentos proliferativos dos tecidos. Adicionalmente, o Ki-67 não sofre influências marcantes da fixação e do processamento histológicos ou da diluição do anticorpo (6,10,19,28,29) . Nossos resultados demonstraram que não houve diferença estatisticamente significativa entre os dois grupos analisados (p = 0,72), fato este também verificado por Donofrio et al (3) , que não encontraram correlação entre presença de HPV e índices aumentados de proliferação celular em lesões cancerizáveis (displasias leves, moderadas e severas) e OSCCs microinvasivos.…”
Section: Discussionunclassified